Take this quiz to test your knowledge about myelofibrosis facts, treatments and other important myelofibrosis facts information. Quiz takes less than 1 minute to complete. A gene mutation in the Janus kinase 2 (JAK2) gene is common in myelofibrosis cases and can help determine prognosis and treatment. True False None Ruxolitinib is a medicine that is a kinase inhibitor, used to treat myelofibrosis with the JAK2 genetic mutation. True False None Currently, allogeneic hematopoietic cell transplant (HCT) is the only chance for a cure, however it is not an option for most patients. True False None Fedratinib is a medicine that is called a kinase inhibitor. It targets the JAK2 genetic mutation commonly detected in myelofibrosis patients. True False None Anemia is very uncommon in myelofibrosis patients True False None Full name Email Phone Time's up
